Browse

Synergistic effects of Akt1 shRNA and paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel on breast cancer

Cited 30 time in Web of Science Cited 31 time in Scopus
Authors
Guo, Ding-Ding; Hong, Seong-Ho; Jiang, Hu-Lin; Kim, Ji-Hye; Minai-Tehrani, Arash; Kim, Ji-Eun; Shin, Ji-Young; Jiang, Tao; Kim, You-Kyoung; Choi, Yun-Jaie; Cho, Chong-Su; Cho, Myung-Haing
Issue Date
2012-03
Citation
Biomaterials, Vol.33 No.7, pp.2272-2281
Keywords
Combination therapyAkt1PaclitaxelBreast cancerPoloxamer hydrogelConjugated linoleic acid
Abstract
The phosphoinositide 3-kinase/Akt1 signaling pathway has emerged as a target for cancer therapy. In this study, we aimed to develop a strategy to enhance Akt-targeted cancer therapy. We hypothesized that combination of Akt1-targeted therapy with conventional chemotherapy using paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel may have synergistic effects in cancer therapeutic efficiency compared with chemotherapy alone. In this study, we found that the combination of shAkt1 with paclitaxel exerted synergistic anti-cancer effects, thus, inhibiting the growth of human breast cancer cells, and breast cancer xenografts in mice as well. The combination therapy demonstrated enhanced anti-cancer effects through inhibiting Akt1 signaling and inducing apoptosis. Our results suggest that the presented strategy of combination of shAkt1 with paclitaxel may have a potential for treatment of breast cancer. (C) 2011 Elsevier Ltd. All rights reserved.
ISSN
0142-9612
URI
https://hdl.handle.net/10371/172333
DOI
https://doi.org/10.1016/j.biomaterials.2011.12.011
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Veterinary Medicine (수의과대학)Dept. of Veterinary Medicine (수의학과)Journal Papers (저널논문_수의학과)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse